2-Cyclopentylethynyl-8-(3-fluoro-phenyl)-9-methyl-9H-purin-6-ylamine

ID: ALA299548

PubChem CID: 10688203

Max Phase: Preclinical

Molecular Formula: C19H18FN5

Molecular Weight: 335.39

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1c(-c2cccc(F)c2)nc2c(N)nc(C#CC3CCCC3)nc21

Standard InChI:  InChI=1S/C19H18FN5/c1-25-18(13-7-4-8-14(20)11-13)24-16-17(21)22-15(23-19(16)25)10-9-12-5-2-3-6-12/h4,7-8,11-12H,2-3,5-6H2,1H3,(H2,21,22,23)

Standard InChI Key:  JZGOLBTTWAAMMN-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 28  0  0  0  0  0  0  0  0999 V2000
    6.5292   -6.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1000   -6.6167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.5292   -5.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4417   -6.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1000   -5.6500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0167   -6.7375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.0167   -5.5375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -5.8417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4917   -6.4292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9625   -6.7250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0417   -6.1750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4292   -7.0125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3667   -5.6750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0250   -4.9375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2917   -7.1917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9667   -5.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042   -7.3042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3042   -5.1875    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    8.3167   -6.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9167   -6.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2417   -6.2250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3542   -7.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8250   -7.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2292   -8.0167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9417   -7.4875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  2  1  0
  5  3  1  0
  6  1  2  0
  7  3  2  0
  8  9  2  0
  9  6  1  0
 10  9  1  0
 11  4  1  0
 12 10  3  0
 13 11  1  0
 14  7  1  0
 15  2  1  0
 16 13  2  0
 17 12  1  0
 18 16  1  0
 19 11  2  0
 20 19  1  0
 21 20  2  0
 22 17  1  0
 23 17  1  0
 24 23  1  0
 25 22  1  0
  5  4  2  0
  8  7  1  0
 21 16  1  0
 24 25  1  0
M  END

Associated Targets(non-human)

Adora2b Adenosine A2b receptor (205 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 335.39Molecular Weight (Monoisotopic): 335.1546AlogP: 3.29#Rotatable Bonds: 1
Polar Surface Area: 69.62Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.68CX LogP: 4.69CX LogD: 4.69
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.69Np Likeness Score: -0.78

References

1. Harada H, Asano O, Hoshino Y, Yoshikawa S, Matsukura M, Kabasawa Y, Niijima J, Kotake Y, Watanabe N, Kawata T, Inoue T, Horizoe T, Yasuda N, Minami H, Nagata K, Murakami M, Nagaoka J, Kobayashi S, Tanaka I, Abe S..  (2001)  2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptor.,  44  (2): [PMID:11170626] [10.1021/jm990499b]

Source